Stock Events

Stock Events

Search...

Halozyme Therapeutics (HALO) Q1 2021 Earnings

23FebConfirmed

Q2 2020

Q3 2020

Q4 2020

Q1 2021

-0.04

0.15

0.35

0.54

Details

Expected EPS

0.54

Actual EPS

0.5

Surprise EPS

-0.04

Surprise Percent

+7.41%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.5 per share for Q1 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.